Related Experiment Video
Updated: May 21, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms
Lynn E Taylor1, Tracy Swan, Kenneth H Mayer
1Department of Medicine, Brown University, Providence, RI 02906, USA. LTaylor@Lifespan.org
Insights
Chronic hepatitis C virus (HCV) infection poses a significant threat to individuals with human immunodeficiency virus (HIV). Early detection and expedited HCV therapy are crucial for improving outcomes in this coinfected population.
Area of Science:
- Hepatology
- Infectious Diseases
- Virology
Background:
- Chronic hepatitis C virus (HCV) infection is a major threat to human immunodeficiency virus (HIV)-infected individuals, particularly where antiretroviral therapy is accessible.
- HCV/HIV coinfection presents challenges in viral eradication, leading to underutilization of HCV therapy, with studies often lagging behind those for HCV monoinfection.
Purpose of the Study:
- To highlight the growing epidemic of HIV/HCV coinfection and the need for improved management strategies.
- To emphasize the importance of novel therapies and expedited clinical trials for coinfected individuals.
- To underscore the association between incident HCV and sexual risk behavior in HIV-infected men who have sex with men.
Main Methods:
- Literature review and synthesis of current understanding regarding HIV/HCV coinfection.
- Analysis of trends in HCV incidence among HIV-infected populations.
- Evaluation of current and potential therapeutic approaches for coinfected individuals.
Main Results:
- HCV infection significantly impacts survival in HIV-positive individuals.
- Aggressive hepatic fibrogenesis is observed when HIV precedes HCV acquisition, necessitating careful monitoring.
- Incident HCV among HIV-infected men who have sex with men is increasingly linked to sexual risk behaviors.
Conclusions:
- Enhanced HCV detection, including annual serologic testing and HCV RNA screening, is vital.
- Earlier intervention and universal consideration for HCV therapy in coinfected patients are recommended.
- Expediting HCV drug trials for coinfected individuals and developing improved care models are essential for managing this evolving epidemic.
Abstract:
Chronic hepatitis C virus (HCV) infection has become a major threat to the survival of human immunodeficiency virus (HIV)-infected persons in areas where antiretroviral therapy is available. In coinfection, viral eradication has been difficult to attain, and HCV therapy is underused. Novel therapies may be particularly beneficial for this population, yet studies lag behind those for HCV monoinfection. Increasingly, incident HCV among HIV-infected men who have sex with men is associated with sexual risk behavior further research should be performed to refine understanding of the causal mechanism of this association. The phenomenon of aggressive hepatic fibrogenesis when HIV infection precedes HCV acquisition requires longer-term observation to ensure optimal timing of HCV therapy. Medical management in coinfection will be improved by enhancing HCV detection, with annual serologic testing, screening with HCV RNA to detect acute infection, and HIV testing of HCV-infected individuals; by addressing HCV earlier in coinfected persons; and by universal consideration for HCV therapy. HCV drug trials in individuals coinfected with HIV should be expedited. HIV/HCV coinfection remains a growing and evolving epidemic; new developments in therapeutics and improved care models offer promise.
Related Concept Videos
Retrovirus Life Cycles
Hepatitis
Viral Hepatitis I: Introduction
Sexually Transmitted Infections
Retroviruses
Mechanisms of Retrovirus-induced Cancers
